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Abstract 
We examined whether the Social Cure (SC) perspective explains the efficacy of a Social 
Prescribing (SP) pathway which addresses healthcare needs through enhancing social 
connections. Data were collected at pathway entry from patients with long-term health 
conditions, or who felt isolated/lonely/socially anxious (N=630), and then again four months 
later (N=178), and six-nine months later (N=63). Being on the pathway was associated with 
increased group memberships between T0 and T1. The relationship between increased group 
memberships and quality-of-life was serially mediated by belonging, support, and loneliness. This 
study is the first to show that SP enhances health/well-being via SC mechanisms.  
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Social Prescribing as ‘Social Cure’: A longitudinal study of the health benefits of social 
connectedness within a Social Prescribing pathway 
Health services are facing economic challenges that are placing them under increasing strain 
(Chang et al., 2019). The UK’s National Health Service (NHS) is no exception: as well as funding 
cuts and the ageing population (ONS, 2018), these challenges include increases in chronic conditions 
such as diabetes (NHS Digital, 2018) and mental illness (NHS England, 2017).  
Much of this illness is exacerbated by loneliness, which is detrimental to mental/physical 
health (e.g., Leigh-Hunt et al., 2017). This may be because loneliness is characterised by a tendency 
to perceive the world as threatening, triggering physiological stress responses which exacerbate illness 
(Cacioppo & Cacioppo, 2018). Lonely people also tend to be frequent primary care attenders, and 
may use this care as a source of much-needed social connection, thereby further burdening services 
(Cruwys, Wakefield, Sani, Dingle, & Jetten, 2018). In sum, there is evidence to suggest that tackling 
healthcare provision challenges (as well as successfully enhancing well-being) requires addressing the 
complex interplay between people’s health and their social worlds.  
Healthcare providers are increasingly aware of this, and have begun to investigate the 
possibility of adopting initiatives designed to address disconnection. By necessity, these initiatives 
involve moving beyond the traditional medical model of healthcare with its focus on medical 
professionals’ roles as medication prescribers, and instead embracing a more holistic approach. This 
principle is at the root of Social Prescribing (SP; Brandling & House, 2009) 
Social Prescribing 
SP’s aim is to enhance the social connections, and consequently, the health/well-being of 
patients experiencing chronic conditions exacerbated by loneliness (e.g., Kimberlee, 2015). In turn, 
such enhancements are predicted to reduce primary healthcare use and improve illness self-
management (Cawston, 2011). SP generally involves health professionals referring patients for 
practical or social support (Kimberlee, 2013). Consistent with its name, SP also includes a social 
dimension, which typically involves patients being supported by ‘Link Workers’ to join 
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voluntary/community groups. SP thus involves three stages: health professional referral to a Link 
Worker; development of a plan between patient and Link Worker; and the patient’s engagement in 
community groups/programmes. This is assumed to enhance sense of community belonging, which is 
thought to boost quality of life/well-being (Rempel, Wilson, Durrant, & Barnett, 2017).  
Evidence suggests that SP initiatives are cost-effective and enhance health/well-being (e.g., 
Kinsella, 2015). However, while SP is a well-developed practice with a strong evidence base, it is not 
guided by a coherent theory of why social connectedness enhances health. This has two consequences. 
First, medical professionals often point to an absence of medical-grade evidence (such as randomised 
controlled trial designs) to support these initiatives (e.g., Bickerdike, Booth, Wilson, Farley, & 
Wright, 2017). Second, in the absence of a theoretical explanation for why SP might have its effects, 
it is unclear how to target, deliver, and capture its effects among different populations. This limits our 
ability to understand how, why, and for whom SP initiatives work. Developing an understanding of 
the processes through which SP initiatives affect health and well-being is vital to inform the 
development of maximally-effective future SP interventions (Bickerdike et al., 2017; Rempel et al., 
2017). With this in mind, we have chosen to approach the current research with a specific theoretical 
framework which takes as its focus the impact of social relationships upon health/well-being: The 
Social Cure perspective. 
Applying the Social Cure Perspective to Social Prescribing 
The Social Cure (SC) perspective (Haslam, Jetten, Cruwys, Dingle, & Haslam, 2018; 
Wakefield, Bowe, Kellezi, McNamara, & Stevenson, 2019) emerged from the Social Identity 
Approach within social psychology (as applied to clinical/health contexts), which investigates the 
impact of social groups on the thoughts and behaviours of their members. It posits that social group 
memberships (e.g., family, community, hobby groups) can enhance health/well-being, but only if 
group members identify with them (i.e., experience a subjective sense of belonging to the group in 
question; Haslam et al., 2017, 2018). The SC perspective suggests that social identities can enhance 
health/well-being through psychological resource provision (Haslam et al., 2018), including a sense of 
connection that engenders feelings of trust; a sense of meaning and purpose in life; and social support 
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from other group members to cope with life’s stresses (Haslam, O'Brien, Jetten, Vormedal, & Penna, 
2005). Together these factors equip group members with resilience, thereby reducing stress and 
improving well-being. Furthermore, the health-related benefits of social groups are enhanced through 
simultaneous membership of multiple groups, which further increase the individual’s sense of social 
connectedness and provide them with multiple (and varied) forms of social support during stressful 
events and life transitions (Iyer, Jetten, Tsivrikos, Postmes, & Haslam, 2009).  
These effects have been found across a range of groups routinely referred to SP initiatives, 
including older adults (Gleibs, Haslam, Haslam, & Jones, 2011) and those living in socioeconomically 
disadvantaged communities (McNamara, Stevenson, & Muldoon, 2013). Possessing multiple group 
memberships within a community context can also encourage the individual to identify more strongly 
with their local community as a whole. This may offer further benefits, as local community 
identification has been shown to positively predict health/well-being (McNamara et al., 2013; Fong, 
Cruwys, Haslam, & Haslam, 2019).  
While the SC perspective has not routinely investigated the impact of group memberships on 
loneliness, it is also likely that an additional way in which social group memberships can positively 
affect well-being is via loneliness reduction. For instance, McIntyre, Worsley, Corcoran, Harrison 
Woods, and Bentall (2018) found that social identification with friendship groups protected university 
students’ psychological health through reduced feelings of loneliness. In an evaluation of the Social 
Cure-based Groups4Health intervention, which is designed to encourage isolated individuals to join 
new social groups and reconnect with old ones, Haslam, Cruwys, Haslam, Dingle, and Chang (2016) 
found that reductions in participants’ loneliness was driven by an increase in their number of group 
identifications, while Haslam et al. (2019) presented RCT evidence of Groups4Health’s ability to 
reduce loneliness. Relatedly, Wakefield, Bowe, Kellezi, Butcher, and Groeger’s (2019) longitudinal 
analyses showed that family identification was a negative predictor of loneliness, which in turn was a 
positive predictor of depression, which itself was a positive predictor of poor sleep quality/insomnia. 
These studies attest to the important role played by social group memberships in loneliness reduction 
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and indicate the ways in which SP initiatives might be able to reduce negative health impacts of 
loneliness through enhancing social group memberships.  
The Present Study 
 The present study is part of a larger programme of research using a multi-method, 
longitudinal approach to explore these processes in an ongoing SP pathway (Authors, 2019a; Authors, 
2018). While our previous work has explored whether the SC perspective captures the experiences of 
healthcare staff and patients in a SP pathway, and whether SC processes help explain the effect of the 
pathway on healthcare usage, this is the first study to longitudinally explore whether an SP pathway 
actually enhances patient quality of life via SC processes. There are five hypotheses, which, together, 
provide a robust test of the efficacy of the SP initiative under investigation, and address our aim of 
exploring the extent to which that efficacy is underpinned by specific SC processes (community 
belonging, social support, and loneliness reduction): 
1.  Before beginning the intervention, SC-related variables such as community belonging and 
social support will correlate positively with participants’ quality of life, while loneliness will 
correlate negatively with quality of life. Observing these relationships would indicate the 
suitability of the sample for SP, and suggest that any SC processes fostered by the SP 
intervention are likely to improve participants’ quality of life.  
2. The SP initiative will improve quality of life over time.  
3. If there are quality of life improvements, they will be caused by an increase in participants’ 
number of group memberships.  
4. Greater number of group memberships during the SP intervention will predict enhanced 
quality of life via SC processes.  
5. Improvements in quality of life and/or number of group memberships will be maintained after 
the SP intervention has concluded. This would provide evidence of long-term benefits.  
We now summarise the specific SP pathway under investigation.  
SP Pathway Overview 
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 This NHS-based SP pathway began in Nottinghamshire in 2017, and is targeted at any 
locally-living adult that is managing one or more long-term physical/mental health conditions, and is 
feeling isolated, lonely, or socially anxious. The pathway supplements regular healthcare and is 
intended to reduce inappropriate healthcare usage by improving illness prevention and self-
management. Over 90% of referrals are made by GPs/practice nurses, but patients may self-refer. 
Once referred, patients’ needs are assessed by a Health Coach (HC), who either recommends self-care 
management, or refers the patient to a community-based Link Worker (LW) who connects patients to 
relevant voluntary/community groups. Patients are re-contacted regularly for progress monitoring.  
Method 
Participants and Procedure  
 All data were gathered during the first two years of the pathway’s operation (November 2017-
Febrary 2019). Baseline (T0) survey data were gathered by HCs from six hundred and fifty-five 
patients before they began the SP intervention. A sample of six hundred and thirty participants was 
included in the present T0 analysis (285 males, 340 females, 5 unknown; Mage = 52.74 years, SD = 
14.79, range = 17-85). These data were gathered in face-to-face meetings at participants’ GP 
surgeries. Data were collected via survey questions which were read out to participants, and the 
responses were recorded by the HC. Verbal informed consent was obtained from all participants. 
Ethical approval was obtained from the West Midlands NHS REC Committee 17/WM/0398. 
 Follow-up 1 (T1) data were collected by HCs around four months after T0 (M = 119.66 days, 
SD = 28.03, range = 62-180 days) during a routine follow-up.1 Data were collected via survey 
questions which were read out to participants (either in-person or via telephone), and responses were 
recorded by the HC. HCs were only able to follow-up some participants due to their busy work 
schedules. This data collection is part of participants’ standard care on the pathway. A sample of 178 
participants were included in the T1 analysis (86 males, 91 females, 1 unknown; Mage = 55.75 years, 
SD = 13.80, range = 19-85 years). Bonferroni-corrected between-groups t-tests were used to compare 
those who were followed-up and those who were not followed up at T1 on all nine variables (critical 
p-value = .05/9 = .006). Followed-ups had significantly more group memberships (M = 1.89, SD = 
Social Prescribing as Social Cure  
 
1.59 vs. M = 1.51, SD = 1.37), t(628) = -2.94, p = .003, and were  older (M = 55.75, SD = 13.80 vs. M 
= 51.56, SD = 15.01), t(625) = -3.22, p = .001. 
Follow-up 2 (T2) data were collected from a subsection of participants by HCs in the same 
manner as the T1 data, six to nine months after T0 (M = 244.78 days, SD = 67.67, range = 103-456 
days). Again, HCs were only able to follow-up some participants due to their busy work schedules. 
Three participants completed their T2 survey less than six months after T0 (103 days, 107 days, and 
115 days respectively), while fourteen completed their T2 survey more than nine months after T0 
(values ranged from 287 days to 456 days). However, due to the relatively small sample size for the 
T2 survey, these data were retained. This led to a sample of 63 participants included in the T2 analysis 
(32 males, 31 females; Mage = 57.13 years, SD = 15.17, range = 24-84 years). Bonferroni-corrected 
between-groups t-tests were used to compare those who were followed-up and those who were not 
followed up at T2 on all nine variables (critical p-value = .05/9 = .006). No comparisons reached the p 
< .006 level of significance, although followed-ups were older (M = 57.13, SD = 15.17 vs. M = 52.25, 
SD = 14.68), t(625) = -2.49, p = .013, and reported poorer health-related quality of life (M = 0.51, SD 
= 0.36 vs. M = 0.62, SD = 0.31), t(73.23) = 2.36, p = .021. 
Measures 
 Number of group memberships. Participants were given a list of ten social groups (“family; 
sports clubs, gyms, or exercise class; tenant group/resident group/neighbourhood watch; political 
party/trade union/environmental group; church or other religious group; education/art/music group, 
or evening class; social club; support group (e.g., diabetes support); any other organisations, club, or 
society”) and were asked to indicate to which they belong. Alternatively, participants could tick “I am 
not a member of any groups”. From this, participants’ number of group memberships was calculated.  
Community belonging. We measured community belonging with a single item previously 
used in population surveys of social attitudes and behaviours, which is known to have good predictive 
ability (Hayward, Dowds, & Shaw, 2014), (“Thinking about this local community, the kind of place it 
is and the kind of people who live around here, would you say that you feel a sense of belonging to 
this local community?”). Participants rated their agreement on a 1 (definitely not) to 4 (yes definitely) 
scale and were asked to define ‘local community’ in any way that was meaningful to them.  
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Social support. Participants’ social support was measured with a four-item scale from 
Haslam et al. (2005). Participants rate their agreement with each item (e.g., “Do you get the emotional 
support you need from other people?”) on a 1 (not at all) to 5 (completely) scale. The mean of the 
items was found, with higher values indicating greater social support. 
Loneliness. We measured loneliness with the eight-item ULS-8 (Hays & DiMatteo, 1987). 
Participants rated their agreement with each item (e.g., “I lack companionship”) on a 1 (not at all) to 5 
(completely) scale. The mean of the items was found, with higher values indicating greater loneliness. 
Health-related quality of life. Participants’ self-reported health-related quality of life (QoL) 
was measured with the EQ5D (EuroQol Group, 1990). Five health dimensions (mobility, self-care, 
usual activities, pain, and anxiety/depression) are each assessed with a single item on a 1-3 scale (e.g., 
mobility: “I have no problems walking about/I have some problems walking about/I am confined to 
bed”). Participants select one option for each item. Calculations were conducted as per the authors’ 
instructions, leading to a score ranging between -0.59 and 1, with higher values indicating better QoL.  
Demographics. Finally, participants were asked to specify their age, gender (male = 1, 
female = 2; other options were available, but all participants identified as either male or female), 
relationship (0 = no, 1 = yes), and education (0 = no qualifications, 1 = school/college qualifications, 
2 = university/work-based qualifications). 
Results 
Do SC-related variables correlate with participants’ quality of life before beginning the SP 
intervention? 
Correlations. As expected, participants’ QoL at T0 correlated positively with number of 
group memberships (r =.11, p = .005), community belonging (r =.22, p < .001), social support (r = 
.21, p < .001), and negatively with loneliness (r = -.33, p < .001). Additionally, number of group 
memberships correlated positively with community belonging (r = .31, p < .001), social support (r = 
.14, p = .01), and negatively with loneliness (r = -.19, p < .001). Community belonging also correlated 
negatively with loneliness (r = -.43, p < .001), and positively with social support (r =.38, p < .001). 
Social support also correlated negatively with loneliness (r = -.50, p < .001).  
Does the SP initiative improve participants’ QoL? 
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Correlations. Although number of groups at T0 did not correlate with QoL at T0 (p = .74), it 
positively correlated with QoL at T1, albeit only approaching significance (p = .072). As expected, 
there was a significant positive correlation between number of groups at T0 and T1 (p = .002), and 
between QoL at T0 and T1 (p < .001). 
ANOVA. To explore the extent to which QoL changed between T0 (immediately pre-
intervention) and T1 (around four months later), a repeated measures analysis of variance (ANOVA) 
was conducted. This revealed that participants’ QoL increased significantly between T0 and T1, 
F(1,177) = 4.26, p = .04. 
Are participants’ QoL improvements over time caused by an increase in their number of group 
memberships?  
Repeated measures analysis of variance. We predicted participants’ number of group 
memberships would increase during their SP participation. As expected, a repeated measures analysis 
of variance (ANOVA) revealed that number of group memberships increased significantly between 
T0 and T1, F(1,177) = 4.07, p = .04. 
Cross-lagged panel analysis. Based on the SC perspective, we predicted that participants’ 
number of group memberships was driving their improvements in QoL over time. To test this, a cross-
lagged panel analysis was conducted using AMOS software. The model is saturated (i.e., all paths 
have been estimated), so fit statistics are unavailable. All regression weights are standardized.  
Number of group memberships at T0 was a significant positive predictor of QoL T1 (beta = .12, p 
= .03). QoL T0 was not a predictor of number of group memberships at T1 (beta = -.04, p = .61). As 
expected, number of group memberships at T0 was a positive predictor of number of group 
memberships at T1 (beta = .23, p = .001), and QoL T0 was a significant positive predictor of QoL T1 
(beta = .68, p < .001). The R2 values for QoL T1 and number of group memberships T1 were .48 
and .06 respectively, indicating that the T0 predictors explained 48%, and 6% of the variance in the 
T1 variables respectively. Overall, this model shows that number of group memberships exerted a 
positive effect on QoL over time, but not vice-versa. 
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Does participants’ change in number of group memberships between T0 and T1 predict 
enhanced QoL via social psychological processes at T1? 
Mediation. A serial mediation analysis was conducted to test the prediction that the change in 
participants’ number of group memberships between T0 and T1 (number of groups at T0 subtracted 
from number of groups at T1) would predict T1 QoL via a chain of three T1 mediators. Specifically, it 
was hypothesised that an increase in number of group memberships between T0 and T1 would 
positively predict sense of community belonging T1, which would positively predict social support 
T1, which would negatively predict loneliness T1, which would negatively predict QoL T1. This 
ordering of variables in consistent with previous Social Cure theorising and research, which argues 
that joining more social groups provides a richer social environment (Iyer et al., 2009), thereby 
allowing people to feel more integrated into their communities. Meanwhile, this sense of community 
belonging encourages people to feel that social support is available from others, helping them feel less 
lonely (Haslam et al., 2018). Finally, since loneliness has well-established negative effects on 
wellbeing (e.g., Wakefield et al., 2019), reducing loneliness is likely to enhance QoL.  
Model 6 in version 3.0 of Hayes’ PROCESS macro was used (as reported above). Age, 
gender, relationship, and education were included as control variables, as were the T0 versions of 
community belonging, social support, loneliness, and QoL. 
Supporting predictions, change in number of group memberships between T0 and T1 was a 
positive predictor of community belonging (coeff = .09, SE = .04, t = 2.55, p = .01, LLCI = .02, ULCI 
= .16), while community belonging T1 was a positive predictor of social support T1 (coeff = .33, SE = 
.08, t = 4.32, p < .001, LLCI = .18, ULCI = .48). In turn, social support T1 was a negative predictor of 
loneliness T1 (coeff = -.23, SE = .08, t = -2.99, p = .003, LLCI = -.38, ULCI = -.08), which itself was a 
negative predictor of QoL T1 (coeff = -.06, SE = .02, t = -2.65, p = .009, LLCI = -.11, ULCI = -.02). 
The indirect effect of change in number of group memberships between T0 and T1 on QoL T1 
through the three T1 mediators was significant (effect = .0004, BootSE = .0003, BootLLCI = .000, 
BootULCI =.0013). The total effect of number of group memberships on QoL was non-significant, 
indicating indirect-only mediation (Zhao, Lynch, & Chen, 2010; effect = -.01, SE = .01, t = -1.17, p = 
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.24, LLCI = -.03, ULCI = .01), and this remained non-significant when the mediators were accounted 
for (effect = -.01, SE = .001, t = -1.51, p = .13, LLCI = -.03, ULCI = .004). 
Were the T1 improvements in QoL and number of group memberships maintained at T2? 
Correlations. Number of groups at T1 did not correlate with QoL at T1 (p = .33), or at T2 (p 
= .68). As expected, there was a significant positive correlation between number of groups at T1 and 
T2 (p = .002), and between QoL at T1 and T2 (p < .001). 
ANOVA. To explore whether the improvements in QoL and number of group memberships 
observed at T1 (around 4 months after recruitment) were maintained at T2 (around 6-9 months after 
recruitment), a repeated measures ANOVA was conducted (n = 63). This revealed that participants’ 
QoL did not change between T1 (M =0.55, SD = 0.38) and T2 (M = 0.59, SD = 0.37), F(1,45) = 0.54, 
p = .47, indicating that the QoL enhancement observed between T0 and T1 was maintained. However, 
participants’ number of group memberships declined significantly between T1 (M = 2.76, SD = 1.65) 
and T2 (M = 1.52, SD = 1.31), F(1,45) = 28.29, p < .001. 
Discussion 
SP is a potentially transformative approach to the delivery of healthcare within community 
settings. The evidence for its economic and therapeutic efficacy is building and, in the UK at least, SP 
has been introduced into healthcare provision. However, as we have argued, SP is a practice in need 
of a theory (Authors, 2019b). Without an understanding of why SP has its impact on health, it remains 
difficult to refine its effects. As a result, a confusing plethora of models with different systems of 
recruitment, engagement, and delivery have emerged, with varying success rates (Kimberlee, 2013), 
which has promoted scepticism from the medical community (e.g. Husk, Elston, Gradinger, 
Callaghan, & Asthana, 2019). In order to transcend this confusion, we wanted to identify the ‘active 
ingredients’ in SP so it can be adapted to meet needs of particular patient groups. We attempted to do 
this by applying a theoretical framework to the evaluation and investigation of the effects of a current 
SP initiative.  
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The SP initiative examined here shares many of the limitations of other programmes: its 
referral criteria are a loose mix of medical and social indicators, its referrals are overwhelmingly from 
GP surgeries (and hence may not represent the wide range of non-clinical loneliness sufferers), and 
patients are rarely referred to activities using clearly-defined therapeutic principles. There is an 
absence of a central theoretical concept to the programme, and no key element is thought to underlie 
patients’ treatment. Yet despite this, the SP programme works. In line with previous studies attesting 
to SP’s benefits (e.g., Potter, 2013; White & Salamon, 2010), our analysis shows significant 
improvements in patient QoL at T1, which are sustained at T2.  
How is this programme working? At recruitment, we see strong relationships between 
participants’ social integration, loneliness, and well-being. These match general patterns identified in 
prior SC research whereby social inclusion, and specifically group memberships, is associated with 
better health. For this sample then, these results suggest the SC model has predictive validity.  
Building on this, our examination of why QoL improves as a result of the intervention again 
points to the pivotal role of these SC processes. First, there is an increase in the range of group 
memberships reported by patients at T1, which parallels the observed health improvements. 
Moreover, our cross-lagged model shows that QoL at T1 is predicted by number of group 
memberships at T0. The number of groups to which a patient initially belongs thus predicts their 
future health, rather than vice versa. On this basis we have evidence of SC factors playing an 
important role in health improvement.  
More definitive evidence is provided by our modelling of the T0 and T1 data. Across T0 and 
T1 we show a specific sequence of variables which mediate the relationship between group 
memberships and QoL. Specifically, the increase in group memberships between the time-points 
predicts an increased sense of community belonging, which in turn increases perceived social support. 
In other words, increased group memberships have their positive impact upon QoL through increasing 
these elements of social inclusion. This aligns with the mass of SC research demonstrating how 
identification with multiple groups can unlock social support from fellow group members to help cope 
with challenges (Iyer et al., 2009). 
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In addition, the model includes loneliness as the third mediating variable, pointing to the 
specific impact of SC processes on health via reduced loneliness (Haslam et al., 2019; McIntyre et al., 
2018; Wakefield et al., 2019). The T0 correlations confirm that loneliness has a negative relationship 
with health-related quality of life before the programme began, while the mediation model indicates 
that SP has its health benefits (at least in part) through loneliness reduction. While SP programmes 
have often suggested that SP has effects through loneliness reduction (see Brandling & House, 2009), 
ours is the first to demonstrate that this is the case, as well as the first to link loneliness to community 
belonging.   
Of course, we must acknowledge the study’s limitations. While our samples at T0 and T1 are 
substantial and afford longitudinal analyses, the attrition at T2 is severe, and does not allow for 
advanced analyses which would determine the specific mediators predicting long-term benefits of this 
intervention. Because the data were gathered by HCs, the predominant reason for this attrition was 
practical: the pathway involved a small number of HCs, whose time was dominated by the fulfilment 
of their work-related duties. T2 data collection took place at an exceptionally busy time for the HCs, 
as the number of patients on the pathway had peaked, and their focus was to ensure that all patients 
received the coaching they needed. This meant that they were unable to follow-up most patients. 
While this is not ideal for research purposes, it reflects the challenges of collecting data in real-world 
interventions with limited HC capacity/funding. It also means that any differences between 
participants who were/were not followed up are unlikely to represent differences in pathway 
engagement.  
Second, our focus is primarily on the social factors impacting upon the entire sample of 
participants, and we acknowledge the particular needs of patients with severe mental health/mobility 
issues which affect social functioning. Further research is required to examine how SP can be adapted 
to the needs of these specific groups. Third, the initiative was developed and delivered within a 
particular socio-economic and demographic context: a relatively affluent, ethnically homogeneous 
suburb of a UK city in which there were many social groups available to participants. While we could 
expect more pronounced social isolation in more deprived/diverse/rural areas, the efficacy of SP will 
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clearly depend upon the community resources available, and the degree to which these can enhance 
community identification.  
Bearing these limitations in mind, we argue that the demonstration of the fundamental role 
played by SC processes in the operation of this programme has key implications for SP’s 
design/delivery. First, our findings place community at the heart of this form of healthcare delivery. 
Often, community is simply seen as a set of resources to be drawn upon by health professionals in 
order to address the healthcare burden. Our research suggests that local community plays a more 
fundamental role than this, impacting directly upon QoL. We know that community identity can shape 
residents’ lives in fundamental ways (Fong et al., 2019). While tailored health activities may well 
address the individual’s specific health needs, greater social inclusion can promote community-wide 
well-being. SP therefore needs to be more explicitly community-health focussed, with a broader goal 
of promoting community cohesion and provision as well as individual patient integration. Indeed, it is 
heartening to see these wider issues being discussed in the NHS’s SP Summary Guide and Long-Term 
Plan (NHS, 2019a, 2019b). 
Second, we propose that the SC processes we have found to be central to SP should be 
embedded in the recruitment of patients. The SP intervention we explored did not clearly articulate 
the social inclusion focus of the programme, leading to the recruitment of a diffuse patient body with 
little understanding of the social factors impacting on their health, or the purpose of SP in reducing 
social isolation. This could create confusion and disengagement if patients’ understandings diverge 
from those of pathway staff (Authors, 2019a). We argue that SP is a unique opportunity to engage 
patients in an open decision-making process regarding how best to harness social factors to improve 
health. For this to happen, SP needs to be clearly advertised as a social intervention, SP providers 
need to be clear about its purpose, and the social, psychological, and health-related benefits of SP 
programmes need to be systematically captured; perhaps in a manner similar to Groups4Health, which 
emphasises this psycho-educational element (Haslam et al., 2016). Ultimately, in order to be 
maximally successful, SP needs to be communicated and delivered as a properly social cure.  
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Footnote 
1We computed an a priori minimum sample size of 34 for a repeated-measures ANOVA, assuming 0.80 
power and a medium-sized partial η2 of .06. Pairwise deletion was used for missing data. 
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Supplementary Table 1                  
Characteristics of the participants at each time-point 
Variable T0 T1 T2 
n 630 
 
178 63 
Age M = 52.74 yrs, SD = 
14.79, range = 17-85 
 
M  = 55.75 yrs, SD = 
13.80, range = 19-85 
M = 57.13 yrs, SD = 
15.17, range = 24-84 
Gender 
 
285 m, 340 f, 5 unknown 86 m, 91 f, 1 unknown 32 m, 31 f 
No. of Group 
Memberships (0-10) 
M = 1.62, SD = 1.45 M = 2.21, SD = 1.87 M = 1.76, SD = 1.98 
Community Belonging 
(1-4) 
M = 2.71, SD = 1.09 M = 2.75, SD = 1.08 M = 2.70, SD = 1.00 
Social Support  
(1-5) 
M = 3.47, SD = 1.19 M = 3.69, SD = 1.11 M = 3.60, SD = 1.14 
Loneliness  
(1-5) 
M = 2.42, SD = 1.18 M = 2.35, SD = 1.00 M = 2.41, SD = 1.17 
Health-Related QoL 
(-0.59-1) 
M = 0.61, SD = 0.32 M = 0.61, SD = 0.33 M = 0.59, SD = 0.36 
Relationship  
(0 = no, 1 = yes) 
0 = 257, 1 = 373 0 = 79, 1 = 99 0 = 25, 1 = 38 
Education (0 = none, 1 = 
schl/coll, 2 = uni/wrk) 
0 = 69, 1 = 276, 2 = 285 0 = 21, 1 = 76, 2 = 81 0 = 9, 1 = 26, 2 = 28 
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Supplementary Table 2                        
T0 (n = 630): Descriptive statistics and correlations 
Variable 1 2 3 4 5 6 7 8 9 
1. No. of Groups 
(0-10; M = 1.62, SD = 1.45) 
-         
2.Community Belonging 
(1-4; M = 2.71, SD = 1.09) 
.31*** -        
3.Social Support 
(1-5; M = 3.47, SD = 1.19, α =.87) 
.14*** .38*** -       
4.Loneliness 
(1-5; M = 2.42, SD = 1.18,  α =.90) 
-.19*** -.43*** -.50*** -      
5.Health-Related Quality of Life 
(-0.59-1.00; M = 0.60, SD = 0.32,  α =.69) 
.11** .22*** .21*** -.33*** -     
6.Age 
(17-85; M = 52.74, SD = 14.79) 
.17*** .15*** .09* -.21*** -.003 -    
7.Gender 
(Male =1, Female = 2) 
.04 .03 -.07† .07† -.08* -.03 -   
8.Relationship 
(Yes = 1, No = 0) 
.09* .18*** .13*** -.31*** .15*** .01 .01 -  
9.Education 
(1 = none, 2 = sch/coll, 3 = uni/wrk) 
.19*** .06* .01 -.05 .13**** .05 .05 .06 - 
Note. ***p ≤ .001, ** p < .01, * p < .05, † p < .10
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Supplementary Table 3 
T0/T1 (n = 178): Descriptive statistics and inter-correlations for key variables 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1. Change in No. of Groups (T0-T1, M = 0.33, SD = 2.15) -              
2. No. of Groups T0 (1-10, M = 1.89, SD = 1.59) -.54*** -             
3. No. of Groups T1 (1-10, M = 2.21, SD = 1.87) .69*** .23** -            
4. Community Belonging T0 (1-4, M = 2.72, SD = 1.12) -.16* .31** .08 -           
5. Community Belonging T1 (1-4, M = 2.75, SD = 1.08) .10 .14† .24** .44*** -          
6. Social Support T0 (1-5, M = 3.61, SD = 1.13, α = .86) -.08 .15† .03 .30*** .30*** -         
7. Social Support T1 (1-5, M = 3.69, SD = 1.11, α = .89) -.10 .07 .05 .23** .45*** .58*** -        
8. Loneliness T0 (1-5, M = 2.42, SD = 1.13, α = .88) .15 -.20** -.001 -.38*** -.29*** -.42*** -.32*** -       
9. Loneliness T1 (1-5, M = 2.35, SD = 1.00, α = .87) .06 -.15* -.06 -.25** -.40*** -.30*** -.47*** .44*** -      
10.Quality of Life T0  (-0.59-1, M = 0.57, SD = 0.35, α = .72) -.05 .03 -.03 .16* .09 .18* .18* -.28** -.22** -     
11.Quality of Life T1 (-0.59-1, M = 0.61, SD = 0.33, α = .74) -.08 .14† .03 .21** .22** .16* .19* -.25** -.30*** .68*** -    
12. Age (M = 55.75, SD = 13.80) -.09 .19* .07 .19* .08 .15* .15* -.26** -.22** .01 .06 -   
13. Gender (1 = male, 2 = female) .01 .14† .13† -.03 -.04 -.07 -.03 -.02 -.11 -.06 -.03 .10 -  
13. Relationship (0 = no, 1 = yes) -.03 .07 .02 .06 .23** .08 .13† -.37*** -.22** .04 .04 .07 .08 - 
14. Education (1 = none, 2 = sch/coll, 3 = uni/wrk) -.06 .23** .13† .10 .03 .05 -.07 -.08 -.11 .20** .23** .15† .09 .04 
Note. *** p < .001, ** p < .01, * p < .05, † p < .10
Social Prescribing as Social Cure  24 
 
 
Supplementary Figure 1. Depiction of sampling flow. 
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Supplementary Figure 2. T0/T1 (n = 178): Cross-lagged panel analysis model. All coefficients are 
standardized. 
  
No. of Groups T0 
Health-Related QoL 
T0 
Health-Related QoL 
T1 
No. of Groups T1 
.12, p = .03 
-.04, p = .61 
.02, p =.74  .03, p = .68 
.06  
.48  
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Supplementary Figure 3. T0/T1 (n = 178): Serial mediation model. C path: total effect outside brackets, direct 
effect inside brackets. Control variables (age, gender, relationship status, education level, T0 community 
belonging, T0 social support, T0 loneliness, T0 health-related quality of life) are not pictured. Note: *** p 
< .001, ** p ≤ .01. 
 
 
Change in 
No. of 
Groups (T1-
T0) 
Community 
Belonging 
T1 
Social 
Support T1 
Loneliness 
T1 
Health-
Related QoL 
T1 
.09** 
.33*** -.23** 
-.06** 
-.01 (-.01) 
